Cell therapy bioprocessing and automation

CELL AND GENE THERAPY INSIGHTS

November 2021

Cell therapy bioprocessing and automation

Download PDF

Expert Insight

Considerations for the development of autologous CAR-T cell products

Considerations for the development of autologous CAR-T cell products

A Davidson, G Santiago Toledo, K Lilova et al.

11 January 2022

Manufacturing of hematopoietic stem cell gene therapies: opportunities for process automation

Manufacturing of hematopoietic stem cell gene therapies: opportunities for process automation

Carlotta Peticone, Emma Chan

20 December 2021

Innovator Insight

Putting the patient first: new modalities of manufacturing for cell therapy though real-time process changes

Putting the patient first: new modalities of manufacturing for cell therapy though real-time process changes

Ben Wang, Kan Wang, Chelsea White

Enabling clinical grade manufacturing of gene-engineered NK cells

Enabling clinical grade manufacturing of gene-engineered NK cells

Nina Möker, Rizwan Romee, Evelyn Ullrich

Improving allogeneic manufacturing workflows

Improving allogeneic manufacturing workflows

Dr. Evan Zynda, Dr. Aditi Singh

4 November 2021

Expert Roundtable

A ddPCR primer: advantages, challenges, and key considerations when adopting Droplet Digital PCR for viral vector manufacture

A ddPCR primer: advantages, challenges, and key considerations when adopting Droplet Digital PCR for viral vector manufacture

L M Drouin, F Dorange, B Silvey et al.

13 December 2021

FastFacts

4D-Nucleofector®️ LV Unit: Efficient, non-viral large-scale transfection for cell and gene therapy applications

4D-Nucleofector®️ LV Unit: Efficient, non-viral large-scale transfection for cell and gene therapy applications

Timo Gleissner, Andrea Toell

13 December 2021

Making billions (of cells) with adherent cell cultures

Making billions (of cells) with adherent cell cultures

Catherine Siler

6 December 2021

Viewpoint

Driving CARs on the biomanufacturing road to clinical success

Driving CARs on the biomanufacturing road to clinical success

Chelsia Qiuxia Wang, Andy Hee-Meng Tan

10 January 2022

Translation and automation hurdles for cell therapies

Translation and automation hurdles for cell therapies

Jenny A Prange, Beatrix Rauch-Schmid

9 December 2021

Interview

Lessons for advanced therapy manufacturing flexibility and productivity

Lessons for advanced therapy manufacturing flexibility and productivity

James Miskin PhD

14 December 2021

Critical success factors for tomorrow’s cellular immunotherapies

Critical success factors for tomorrow’s cellular immunotherapies

13 December 2021

Webinars

Automated cell expansion: Current technologies and trends

Automated cell expansion: Current technologies and trends

D Sethi PhD, A Kilgore PhD, K Schneider

9 November 2021

Magnetic selection for consistent cellular starting material in autologous cell therapy manufacture

Magnetic selection for consistent cellular starting material in autologous cell therapy manufacture

Kenneth Olsen PhD, Rachel Perret PhD

23 November 2021

Enabling clinical grade manufacturing of gene-engineered NK cells

Enabling clinical grade manufacturing of gene-engineered NK cells

N Möker, E Ullrich MD, R Romee MD et al.

30 November 2021

Developing stem cell therapies: expansion strategies and lessons learned

Developing stem cell therapies: expansion strategies and lessons learned

S Mei PhD MSc, L McIntyre MD MHSc FRCPC, C Siler PhD

8 December 2021

Putting the patient first: New modalities of manufacturing for cell therapy through real-time process changes

Putting the patient first: New modalities of manufacturing for cell therapy through real-time process changes

C C White III, B Wang, K Wang

9 December 2021